Building a Data-Driven Future for Cancer Care

Cancer Image Europe is pioneering a pan-European federated infrastructure for cancer images, fueling AI innovations

Cancer Image Europe provides a robust, trustworthy platform for researchers, clinicians, and innovators to access diverse cancer images, enabling the benchmarking, testing, and piloting of AI-driven technologies.

By connecting high-quality cancer image data and AI experts, Cancer Image Europe facilitates collaboration and accelerates the development of cutting-edge solutions for cancer diagnosis and treatment.

Accelerating Innovations in Cancer Diagnosis and Treatment

Federated Research Infrastructure

EUCAIM aims to build a pan-European federated infrastructure for cancer images, connecting top cancer research institutions and making diverse cancer images available to researchers, clinicians, and innovators.

Artificial Intelligence Innovations

By providing access to a vast collection of cancer images, EUCAIM enables the development, benchmarking, testing, and piloting of AI-based technologies for cancer diagnosis and treatment.

Collaboration and Exchange

EUCAIM seeks to enhance collaboration between cancer research institutions, AI experts, and industry stakeholders to accelerate the development of cutting-edge diagnostic and treatment solutions.

Improved Outcomes for Cancer Patients

The ultimate objective of the EUCAIM project is to empower the next generation of cancer diagnostics and treatments, leading to improved patient outcomes and transforming cancer care across Europe.

The Cancer Image Europe platform is unique because it will foster the transition from research into clinical practice

To support research and development of new AI tools for cancer and ensure a seamless transition into clinical practice, we have divided our work plan into eight distinct work packages. These work packages cover diverse aspects such as data collection, infrastructure development, AI model evaluation, and dissemination, all of which are designed to facilitate effective collaboration, innovation, and the ultimate integration of these advancements into clinical practice across the cancer imaging ecosystem.

Project achievements and resources

Explore our latest scientific publications, public deliverables and reports, and innovative online tools designed to advance cancer diagnostics and treatment.

Newsroom

Testimonials

The EUCAIM Consortium

The EUCAIM consortium consist of 76 partners from 14 countries. Many partners are part of the “AI for Health Imaging” Network (AI4HI), a cluster of 5 large EU-funded projects on big data and AI in cancer imaging (CHAIMELEON, EUCANIMAGE, INCISIVE, ProCancer-I, PRIMAGE), whose data repositories EUCAIM is building on. The Consortium also involves major European Research Infrastructures, such as Euro-BioImaging, BBMRI, EATRIS and ELIXIR. Overall, in the EUCAIM consortium, public and private entities, many prestigious universities, private companies, and hospitals are represented to ensure that all of the necessary expertise are brought together for the success of EUCAIM.

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.